Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

Non Alcoholic Fatty Liver Disease and Endogenous Oxalate Synthesis

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study aims to determine the daily rate of endogenous synthesis of oxalate using fasted urine collection and a low-oxalate controlled diet in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Who May Be Eligible (Plain English)

Who May Qualify: - age \>18 years - History of MASLD, with liver fat content \> 5% - Normal kidney function - Stable medication for at least 1 month for diabetes mellitus if any - Willingess to ingest fixed diets and stop dietary supplements for the study and come to UAB for visits Who Should NOT Join This Trial: - Age \< 18 years - Inaccurate 24-hour urine collections - Liver fat content \<5% - Liver cirrhosis - Evidence of other chronic liver disease, viral hepatitis - history of alcoholism within 2 years of enrollment - Contra-indication to Magnetic Resonance Imaging - Chronic kidney disease with estimated Glomerular Filtration rate \< 60 ml/min/1.73m2 - Type 1 Diabetes Mellitus or treatment with insulin - Uncontrolled diabetes - Pregnancy, lactation or intention to be - Uncontrolled hypertension - Use of weight loss medication, SGLT2 inhibitors, GLP-1 receptor agonists, osteoporosis medication, chronic NSAID - History of gastric or intestinal surgery or resection that could potentially alter oxalate absorption - Chronic fat malabsorption - Use of immunosuppressive medications - Known immuno-compromised status - Active malignancy or treatment for malignanacy within the last 12 months Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * age \>18 years * History of MASLD, with liver fat content \> 5% * Normal kidney function * Stable medication for at least 1 month for diabetes mellitus if any * Willingess to ingest fixed diets and stop dietary supplements for the study and come to UAB for visits Exclusion Criteria: * Age \< 18 years * Inaccurate 24-hour urine collections * Liver fat content \<5% * Liver cirrhosis * Evidence of other chronic liver disease, viral hepatitis * history of alcoholism within 2 years of enrollment * Contra-indication to Magnetic Resonance Imaging * Chronic kidney disease with estimated Glomerular Filtration rate \< 60 ml/min/1.73m2 * Type 1 Diabetes Mellitus or treatment with insulin * Uncontrolled diabetes * Pregnancy, lactation or intention to be * Uncontrolled hypertension * Use of weight loss medication, SGLT2 inhibitors, GLP-1 receptor agonists, osteoporosis medication, chronic NSAID * History of gastric or intestinal surgery or resection that could potentially alter oxalate absorption * Chronic fat malabsorption * Use of immunosuppressive medications * Known immuno-compromised status * Active malignancy or treatment for malignanacy within the last 12 months

Treatments Being Tested

DIETARY_SUPPLEMENT

Low-oxalate fixed diet

Ingestion of a low-oxalate (\< 60 mg/day) , normal calcium (800-1200 mg/d) eucaloric diet for 5 days

Locations (1)

University of Alabama at Birmingham
Birmingham, Alabama, United States